NEW YORK (TheStreet) -- RATINGS CHANGES
Aetna (AET) was upgraded to buy from hold at Cantor Fitzgerald. $140 price target. Estimates were also increased, given the Humana acquisition, said Cantor Fitzgerald.
La Quinta (LQ) was downgraded to neutral from overweight at JPMorgan. $20 price target. The CEO change is a surprise and the company lacks near-term catalysts, said JPMorgan.
La Quinta (LQ) was downgraded to neutral at Citigroup. $21 price target. The company reduced guidance for a second time, Citi said.
Valspar (VAL) was upgraded to overweight from neutral at JPMorgan. $83 price target. This was a valuation call, as the stock has pulled back 10%, said JPMorgan.